![Katherine Bishop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katherine Bishop
Director/Board Member at
DTx Pharma, Inc.
Profile
Katherine M.
Bishop is currently the Director at DTx Pharma, Inc. since 2022 and the SVP, Head-Rare Disease & External Innovation at ACADIA Pharmaceuticals, Inc. since 2021.
Previously, she worked as the Director-Preclinical Research & Development at Ceregene, Inc. from 2001 to 2009, Vice President-Clinical Development at Ionis Pharmaceuticals, Inc. from 2009 to 2015, Chief Scientific Officer at Tioga Pharmaceuticals, Inc. in 2015, Chief Scientific Officer at Otonomy, Inc. from 2017 to 2019, and Chief Scientific Officer at Locanabio, Inc. from 2019 to 2020.
Dr. Bishop holds a doctorate degree from the University of Alberta, and undergraduate degrees from the University of British Columbia and Simon Fraser University.
Katherine Bishop active positions
| Companies | Position | Start |
|---|---|---|
DTx Pharma, Inc.
 DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications | Director/Board Member | 02/05/2022 |
Former positions of Katherine Bishop
| Companies | Position | End |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
Locanabio, Inc.
 Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Chief Tech/Sci/R&D Officer | 01/12/2020 |
| OTONOMY | Chief Tech/Sci/R&D Officer | 01/07/2019 |
Tioga Pharmaceuticals, Inc.
 Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of gastrointestinal diseases | Chief Tech/Sci/R&D Officer | 01/11/2016 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2015 |
Training of Katherine Bishop
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for neurodegenerative disorders | Health Technology |
Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of gastrointestinal diseases | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
DTx Pharma, Inc.
DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications | Health Technology |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Technology Services |
- Stock Market
- Insiders
- Katherine Bishop
